Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/56010
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tim R. Cressey | en_US |
dc.contributor.author | Rohan Hazra | en_US |
dc.contributor.author | Andrew Wiznia | en_US |
dc.contributor.author | Marc Foca | en_US |
dc.contributor.author | Patrick Jean-Philippe | en_US |
dc.contributor.author | Bobbie Graham | en_US |
dc.contributor.author | Jennifer R. King | en_US |
dc.contributor.author | Paula Britto | en_US |
dc.contributor.author | Vincent J. Carey | en_US |
dc.contributor.author | Edward P. Acosta | en_US |
dc.contributor.author | Ram Yogev | en_US |
dc.date.accessioned | 2018-09-05T03:07:42Z | - |
dc.date.available | 2018-09-05T03:07:42Z | - |
dc.date.issued | 2016-11-28 | en_US |
dc.identifier.issn | 15320987 | en_US |
dc.identifier.issn | 08913668 | en_US |
dc.identifier.other | 2-s2.0-84984700603 | en_US |
dc.identifier.other | 10.1097/INF.0000000000001320 | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84984700603&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/56010 | - |
dc.description.abstract | © 2016 Wolters Kluwer Health, Inc. All rights reserved. HIV protease inhibitor use in pediatrics is challenging due to the poor palatability and/or toxicity of concomitant low-dose ritonavir. Atazanavir without ritonavir (unboosted) is not recommended for patients with prior virologic failure, a common problem for perinatally-infected adolescents. Atazanavir 400 mg once-daily provided suboptimal exposure. Higher unboosted doses or splitting the daily dose to twice-daily warrants investigation in this treatment-experienced population. | en_US |
dc.subject | Medicine | en_US |
dc.title | Pharmacokinetics of unboosted atazanavir in treatment-experienced HIV-infected children, adolescents and young adults | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Pediatric Infectious Disease Journal | en_US |
article.volume | 35 | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
article.stream.affiliations | Harvard School of Public Health | en_US |
article.stream.affiliations | National Institute of Child Health and Human Development | en_US |
article.stream.affiliations | Jacobi Medical Center | en_US |
article.stream.affiliations | Columbia University Medical Center | en_US |
article.stream.affiliations | National Institute of Allergy and Infectious Diseases | en_US |
article.stream.affiliations | Frontier Science and Technology | en_US |
article.stream.affiliations | University of Alabama at Birmingham | en_US |
article.stream.affiliations | Northwestern University Feinberg School of Medicine | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.